These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 989496

  • 21. Neuroleptic drugs and the dopamine hypothesis.
    Clow A, Jenner P, Theodorou A, Marsden CD.
    Lancet; 1979 Apr 28; 1(8122):934. PubMed ID: 86713
    [No Abstract] [Full Text] [Related]

  • 22. Effects of antipsychotic drugs on the long-term effects of amphetamine on nigro-striatal dopamine neurons in iprindole-treated rats.
    Steranka LR.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar 28; 325(3):198-204. PubMed ID: 6145099
    [Abstract] [Full Text] [Related]

  • 23. Effects of baclofen on dopamine metabolism and interaction with neuroleptic effects.
    Waldmeier PC, Maitre L.
    Eur J Pharmacol; 1978 Jan 15; 47(2):191-200. PubMed ID: 23298
    [Abstract] [Full Text] [Related]

  • 24. Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol.
    Teicher MH, Barber NI, Gelbard HA, Gallitano AL, Campbell A, Marsh E, Baldessarini RJ.
    Neuropsychopharmacology; 1993 Sep 15; 9(2):147-56. PubMed ID: 8216697
    [Abstract] [Full Text] [Related]

  • 25. Correlation between catalepsy and dopamine decrease in the rat striatum induced by neuroleptics.
    Honma T, Fukushima H.
    Neuropharmacology; 1976 Oct 15; 15(10):601-7. PubMed ID: 1033478
    [No Abstract] [Full Text] [Related]

  • 26. Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover.
    Lerner P, Nosé P, Gordon EK, Lovenberg W.
    Science; 1977 Jul 08; 197(4299):181-3. PubMed ID: 17917
    [Abstract] [Full Text] [Related]

  • 27. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
    Zetterström T, Sharp T, Ungerstedt U.
    Eur J Pharmacol; 1984 Oct 30; 106(1):27-37. PubMed ID: 6085051
    [Abstract] [Full Text] [Related]

  • 28. Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration.
    Scatton B.
    Eur J Pharmacol; 1977 Dec 15; 46(4):363-9. PubMed ID: 590344
    [Abstract] [Full Text] [Related]

  • 29. Regional selectivity of neuroleptic drugs: an argument for site specificity.
    Borison RL, Diamond BI.
    Brain Res Bull; 1983 Aug 15; 11(2):215-8. PubMed ID: 6138135
    [Abstract] [Full Text] [Related]

  • 30. Biphasic influence of a 8 alpha-amino ergoline, CU 32-085, on striatal dopamine synthesis and turnover in vivo in the rat.
    Enz A.
    Life Sci; 1981 Nov 23; 29(21):2227-34. PubMed ID: 6119592
    [No Abstract] [Full Text] [Related]

  • 31. Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Batool F, Hasnat A, Haleem MA, Haleem DJ.
    Acta Pharm; 2010 Jun 23; 60(2):129-40. PubMed ID: 21134850
    [Abstract] [Full Text] [Related]

  • 32. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y, Komori T, Okuda S, Segawa T.
    Arch Int Pharmacodyn Ther; 1979 Jan 23; 237(1):25-30. PubMed ID: 485682
    [Abstract] [Full Text] [Related]

  • 33. Apomorphine- and haloperidol-induced change in 3,4-dihydroxyphenylacetic acid content in the mesolimbic-striatum of the developing rat.
    Nomura Y, Oki K, Segawa T.
    J Pharmacobiodyn; 1980 Feb 23; 3(2):111-6. PubMed ID: 7205536
    [Abstract] [Full Text] [Related]

  • 34. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response.
    Deutch AY, Tam SY, Freeman AS, Bowers MB, Roth RH.
    Eur J Pharmacol; 1987 Feb 24; 134(3):257-64. PubMed ID: 3569414
    [Abstract] [Full Text] [Related]

  • 35. Utilization of microdialysis for assessing the release of mesotelencephalic dopamine following clozapine and other antipsychotic drugs.
    Moghaddam B, Bunney BS.
    Prog Neuropsychopharmacol Biol Psychiatry; 1990 Feb 24; 14 Suppl():S51-7. PubMed ID: 2097674
    [Abstract] [Full Text] [Related]

  • 36. beta-Endorphin-induced increase in striatal dopamine turnover.
    van Loon GR, Kim C.
    Life Sci; 1978 Sep 04; 23(9):961-70. PubMed ID: 703526
    [No Abstract] [Full Text] [Related]

  • 37. Serotoninergic modulation of mesolimbic and frontal cortical dopamine neurons.
    Waldmeier PC.
    Experientia; 1980 Sep 15; 36(9):1092-4. PubMed ID: 6448165
    [Abstract] [Full Text] [Related]

  • 38. The nucleus accumbens--possible site of antipsychotic action of neuroleptic drugs?
    Crow TJ, Deakin JF, Longden A.
    Psychol Med; 1977 May 15; 7(2):213-21. PubMed ID: 560024
    [Abstract] [Full Text] [Related]

  • 39. Behavioral and biochemical correlates after haloperidol and clozapine long-term treatment.
    Racagni G, Bruno F, Bugatti A, Parenti M, Apud JA, Santini V, Carenzi A, Groppetti A, Cattabeni F.
    Adv Biochem Psychopharmacol; 1980 May 15; 24():45-51. PubMed ID: 7405672
    [No Abstract] [Full Text] [Related]

  • 40. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment.
    Nishikawa T, Mataga N, Takashima M, Toru M.
    Eur J Pharmacol; 1983 Mar 25; 88(2-3):195-203. PubMed ID: 6133769
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.